CYLD suppresses infectious Bursal disease virus replication by deubiquitinating VP1

Qinghua Zeng1, Manzi Huang1, Boqian Zha1

  • 1Department of Veterinary Preventive Medicine, College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang 330045, PR China; Jiangxi Provincial Key Laboratory for Animal Health, College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang 330045, PR China.

Veterinary Microbiology
|August 27, 2025
PubMed

Insights

Cylindromatosis (CYLD) deubiquitinase inhibits infectious Bursal disease virus (IBDV) replication by targeting viral protein VP1. Viral protein VP3 disrupts this interaction, promoting IBDV replication, highlighting CYLD as a potential therapeutic target.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Cylindromatosis (CYLD) is a deubiquitinase (DUB) involved in regulating signaling pathways and has emerging roles in antiviral immunity.
  • The function of CYLD in infectious Bursal diseases virus (IBDV) infection is not well understood.

Purpose of the Study:

  • To investigate the role of CYLD in IBDV infection and elucidate the underlying molecular mechanisms.
  • To identify potential therapeutic targets for IBDV infection.

Main Methods:

  • Coimmunoprecipitation and mass spectrometry to identify CYLD-interacting proteins.
  • Overexpression and knockout/knockdown studies in DF-1 cells to assess CYLD's effect on IBDV replication.
  • In vivo and in vitro expression analysis of CYLD during IBDV infection.
  • Site-directed mutagenesis to identify critical residues in CYLD's enzymatic activity.

Main Results:

  • CYLD directly binds to IBDV protein VP1.
  • CYLD overexpression inhibits IBDV replication, while CYLD deficiency enhances it, independent of the interferon pathway.
  • IBDV infection upregulates CYLD expression.
  • CYLD deubiquitinates VP1, reducing its polymerase activity and inhibiting viral replication.
  • A specific catalytic residue (C602) in CYLD is crucial for its enzymatic activity and VP1 interaction.
  • Viral protein VP3 antagonizes CYLD's antiviral activity by disrupting the CYLD-VP1 interaction.

Conclusions:

  • CYLD plays a significant role in antiviral immunity against IBDV by targeting VP1 deubiquitination and activity.
  • The VP3-CYLD-VP1 axis is critical for regulating IBDV replication.
  • CYLD represents a potential therapeutic target for controlling IBDV infections.

Related Concept Videos

Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
208
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
114
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
217
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
111
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.9K